Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH   3:59:53 PM EDT
6.83
+0.24 (+3.64%)
Other Pre-Announcement

Cyclo Therapeutics Reports Q4 And FY20 Financial Results

Published: 03/15/2021 12:57 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results.
Ctd Holdings Inc - Company Expects to Commence Enrollment in Pivotal Phase 3 Study of Trappsol(®) Cyclo™ for Npc in Q2 2021.
Ctd Holdings Inc - Ind Filing for Trappsol(®) Cyclo™ Alzheimer's Disease Program on Track for H2 2021.
Ctd Holdings Inc - Npc Pivotal Phase 3 Study Interim Analysis Topline Results Expected in Q4 2022.